zenon 20 mg / 10 mg
sanofi-aventis norge as - rosuvastatinkalsium / ezetimib - tablett, filmdrasjert - 20 mg / 10 mg
zenon 10 mg / 10 mg
sanofi-aventis norge as - rosuvastatinkalsium / ezetimib - tablett, filmdrasjert - 10 mg / 10 mg
zenon 40 mg / 10 mg
sanofi-aventis norge as - rosuvastatinkalsium / ezetimib - tablett, filmdrasjert - 40 mg / 10 mg
zenon 40 mg / 10 mg
paranova as - rosuvastatinkalsium / ezetimib - tablett, filmdrasjert - 40 mg / 10 mg
zenon 10 mg / 10 mg
orifarm as - rosuvastatinkalsium / ezetimib - tablett, filmdrasjert - 10 mg / 10 mg
zenon 20 mg / 10 mg
orifarm as - rosuvastatinkalsium / ezetimib - tablett, filmdrasjert - 20 mg / 10 mg
zenon 40 mg / 10 mg
orifarm as - rosuvastatinkalsium / ezetimib - tablett, filmdrasjert - 40 mg / 10 mg
epidyolex
jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptics, - epidyolex er indikert for bruk som adjuvant behandling av anfall assosiert med lennox gastaut syndrom (lgs) eller dravet syndrom (ds), i forbindelse med clobazam, for pasienter fra 2 år og eldre.
inovelon
eisai gmbh - rufinamide - epilepsi - antiepileptics, - inovelon er indisert som tilleggsbehandling ved behandling av anfall assosiert med lennox gastaut syndrom hos pasienter som er 4 år og eldre.
fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.